Please login or sign up to post and edit reviews.
DOJ Accuses Visa of Being a Monopoly & Ozempic Prices Grilled by Congress
Publisher |
Morning Brew
Media Type |
audio
Podknife tags |
Business
Business News
Interview
Categories Via RSS |
Business
Business News
News
Publication Date |
Sep 25, 2024
Episode Duration |
00:32:25
Episode 417: Neal and Toby discuss the latest DOJ battle against a big company, this time against Visa, alleging it monopolizes the debit card business. Then, FTX fraudster and key witness Caroline Ellison cooperates with the courts but receives 2 years in prison. Also, the CEO of Novo Nordisk stands before Congress to answer if Ozempic’s price is too out of reach for Americans. Meanwhile, a port strike across the East and Gulf Coasts could result in a supply chain nightmare. Plus, popular tech reviewer MKBHD, known for his unfettered reviews of products, releases a product of his own. Now it’s open season for other reviewers. Lastly, the Chicago White Sox is on the brink of being the worst team in baseball history. How did they get there? Subscribe to Morning Brew Daily for more of the news you need to start your day, share the show with a friend, and leave us a review on your favorite podcast app. To learn more about how Wise could work for your business, visit https://wise.com/business/  Checkout Brew Markets Here Get your Morning Brew Daily T-Shirt HERE: https://shop.morningbrew.com/products/morning-brew-radio-t-shirt?_pos=1&_sid=6b0bc409d&_ss=r&variant=45353879044316  Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow 00:00 - Mini Moon 03:10 - Visa Lawsuit 08:30 - Caroline Ellison Sentencing  12:09 - Novo Nordisk Ozempic Prices 17:45 - East Coast Port Strike 23:00 - MKBHD Panels App Review 26:40 - White Sox Woes Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review